Brown Advisory’s AbbVie ABBV Stock Holding History

Brown Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,000	Closed	-$1K	–	1037
2019 Q3	$1K	Buy	+1,000	New	+$68.6K	﹤0.01%	1005

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brown Advisory's ABBV Position: Q2 2026 in Review

Brown Advisory reduced its AbbVie (ABBV) stake by 0.46% in Q2 2026, selling an estimated $867K and leaving 870,702 shares worth $219M. The position accounts for 0.34% of the portfolio, ranked #68.

Brown Advisory first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Brown Advisory held 870,702 shares of AbbVie worth $219M as of Q2 2026.
Brown Advisory sold 4,029 AbbVie shares in Q2 2026, an estimated $867K.
AbbVie made up 0.34% of Brown Advisory's portfolio in Q2 2026, its #68 holding.
Brown Advisory first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.